Treatment of Chronic Peripheral Arterial Disease
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
205-216
Author(s):
P. L. Antignani
Genetic Variations of the Hemostatic System as Risk Factors for Venous and Arterial Thrombotic Disease
Journal:
Current Genomics
Volume:
4
Page:
309-336
Author(s):
R. F. Franco, M. D. Trip and P. H. Reitsma
Nicotine, Body Weight and Potential Implications in the Treatment of Obesity
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
899-919
Author(s):
Ming D. Li, Justin K. Kane and Ozlen Konu
Protein kinases and the Hypoxia-Inducible Factor-1, two switches in angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
531-541
Author(s):
N. M. Mazure, M. C. Brahimi-Horn and J. Pouysségur
Human Tissue Kallikrein: A New Bullet for the Treatment of Ischemia
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
589-597
Author(s):
Costanza Emanueli and Paolo Madeddu
The Renin-Angiotensin System: The Role of Inhibitors, Blockers, and Genetic Polymorphisms in the Treatment and Prevention of Heart Failure
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
33-39
Author(s):
Patricia R. Hebert, JoAnne M. Foody and Charles H. Hennekens
Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
95-117
Author(s):
S. Shinkaruk, M. Bayle, G. Lain and G. Deleris
Gene Therapy in Cardiovascular Diseases
Journal:
Current Gene Therapy
Volume:
2
Page:
427-435
Author(s):
Kamala P. Tamirisa and Debabrata Mukherjee
Multiple Drug Targets in the Management of Type 2 Diabetes
Journal:
Current Drug Targets
Volume:
3
Page:
203-221
Author(s):
M.H. Moneva and S. Dagogo-Jack
Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Journal:
Current Drug Targets
Volume:
1
Page:
247-260
Author(s):
M. A. Khan, R. C. Calvert, M. E. Sullivan, C. S. Thomson, F. H. Mumtaz, R. J. Morgan and D. P. Mikhailidis